Association of methylenetetrahydrofolate reductase (C677T) polymorphism with hyperuricemia

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 17, Issue 6, 2007, Pages 462-467

  Golbahar, Jamal ^a,b   Aminzadeh, Mohammad A ^b   Al Shboul, Qasim M ^c   Kassab, Salah ^c   Rezaian, Golam R ^b  

^a Medical Sciences   (Bahrain)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

5,10 Methylenetetrahyrofolate reductase; Association; Hyperuricemia

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); URIC ACID;

ADULT; AGED; ARTICLE; BLOOD; ENZYMOLOGY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERURICEMIA; IRAN; MALE; MIDDLE AGED; PHENOTYPE; RISK; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

ADULT; AGED; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPERURICEMIA; IRAN; LINEAR MODELS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS; URIC ACID;

EID: 34447514242     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2006.02.002     Document Type: Article

References (27)

1. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
2. Kang S.S., Wong P.W.K., Susmano A., Sora J., Norusis M., and Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 48 (1991) 536-545
3. Kirke P.N., Mills J.L., Whitehead A.S., Molloy A., and Scott J.M. Methylenetetrahydrofolate reductase mutation and neural tube defects. Lancet 348 (1996) 1037-1038
4. de Franchis R., Sebastio G., Mandato C., Andria G., and Mastroiacovo P. Spina bifida, 677TC mutation and role of folate. Lancet 346 (1995) 1703
5. Engbersen A.M.T., Franken D.G., Boers G.H.J., Stevens E.M.B., Trijbels F.J.M., and Blom H.J. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 56 (1995) 142-150
6. Golbahar J., Fathi Z., and Tamadon M.A. Distribution of 5, 10 methylenetetrahydrofolate reductase and its association with red blood cell 5-methyltetrahyrofolate in the healthy Iranians. Clin Nutr 24 (2005) 83-87
7. Kang S.S., Zhou J., Wong P.W.K., Kowalisyn J., and Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 43 (1988) 414-421
8. Klerk M., Verhoef P., Clarke R., Blom H.J., Kok F.J., and Schouten E.G. MTHFR Studies Collaboration Group. MTHFR 677C → T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288 (2002) 2023-2031
9. de Franchis R., Botto L.D., Sebastio G., Ricci R., Iolascon A., Capra V., et al. Spina bifida and folate-related genes: a study of gene-gene interactions. Genet Med 4 (2002) 126-130
10. Ou C.Y., Stevenson R.E., Brown V.K., Schwartz C.E., Allen W.P., Khoury M.J., et al. 5,10-Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 63 (1996) 610-614
11. Coull B.M., Malinow M.R., Beamer N., Sexton G., Nordt F., and de Garmo P. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke 21 (1990) 572-576
12. Evers S., Koch H.G., Grotemeyer K.H., Lange B., Deufel T., and Ringelstein E.B. Features, symptoms, and neurophysiological findings in stroke associated with hyperhomocysteinemia. Arch Neurol 54 (1997) 1276-1282
13. Malinow M.R., Levenson J., Giral P., Nieto F.J., Razavian M., Segond P., et al. Role of blood pressure, uric acid, and hemorheological parameters on plasma homocyst(e)ine concentration. Atherosclerosis 114 (1995) 175-183
14. Motti C., Gnasso A., Bernardini S., Massoud R., Pastore A., Rampa P., et al. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine and other risk factors for vascular disease. Atherosclerosis 139 (1998) 377-383
15. Culleton B.F., Larson M.G., Kannel W.B., and Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131 (1999) 7-13
16. Lehto S., Niskanen L., Ronnemaa T., and Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 29 (1998) 635-639
17. Whitfield J.B., and Martin N.G. Inheritance and alcohol as factors influencing plasma uric acid levels. Acta Genet Med Gemellol Roma 32 (1983) 117-126
18. Emmerson B.T., Nagel S.L., Duffy D.L., and Martin N.G. Genetic control of the renal clearance of urate: a study of twins. Ann Rheum Dis 51 (1992) 375-377
19. Seegmiller J.E., Rosenbloom F.M., and Kelly W.N. Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science 155 (1967) 1682-1684
20. Sperling O., Persky-Brosh S., Boer P., and De Vries A. Human erythrocyte phosphoribosylpyrophosphate synthetase mutationaly altered in regulatory properties. Biochem Med 7 (1973) 389-395
21. Zuo M., Nishio H., Lee M.J., Maejima K., Mimura S., and Sumino K. The C677T mutation in the methylene tetrahydrofolate reductase gene increases serum uric acid in elderly men. J Hum Genet 45 (2000) 257-262
22. Lwin H., Yoshiike N., Yokoyama T., Saito K., Date C., and Tanaka H. The relationships between plasma total homocysteine and selected atherosclerotic risk factors according to the C677T methylenetetrahydrofolate reductase gene in Japanese. Eur J Cardiovasc Prev Rehabil 12 (2005) 182-184
23. Cannon P.J., Stason W.B., Demartini F.E., Sommers S.C., and Laragh J.H. Hyperuricemia in primary and renal hypertension. N Engl J Med 275 (1966) 457-464
24. Fang J., and Alderman M.H. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 283 (2000) 2404-2410
25. Russo C., Olivieri O., Girelli D., Guarini P., and Corrocher R. Relationships between serum uric acid and lipids in healthy subjects. Prev Med 25 (1996) 611-616
26. Ferns G.A., Lanham J., Dieppe P., and Galton D.J. A DNA polymorphism of an apoprotein gene associates with the hypertriglyceridaemia of primary gout. Hum Genet 78 (1988) 55-59
27. Moriwaki Y., Yamamoto T., Takahashi S., Tsutsumi Z., and Higashino K. Apolipoprotein E phenotypes in patients with gout: relation with hypertriglyceridaemia. Ann Rheum Dis 54 (1995) 351-354